chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Numbness; Tickling / Paraesthecia in the right arm and in the half part of face; This case was reported by a physician via call center representative and described the occurrence of paresthesia in a 78-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 30th January 2020, the patient received Shingrix. On 31st January 2020, 1 days after receiving Shingrix, the patient experienced paresthesia. On an unknown date, the patient experienced numbness. On an unknown date, the outcome of the paresthesia and numbness were unknown.   It was unknown if the reporter considered the paresthesia and numbness to be related to Shingrix.  Additional details were reported as follows: The patient received Shingrix and experienced a tickling, numbness and paraesthecia in the right arm and in the half part of her face. Reporter consented to follow up.
1-2 days after 2nd dose of Pfizer vaccine, patient started to experience dyspnea, chest discomfort, fatigue and fatigability, palpitations, loss of exercise tolerance
He thinks he has angioedema/suspected angioedema; swelling all over his face; He has big water bags under his eyes; my eyes are still swollen up; This is a spontaneous report from a contactable consumer reporting for himself   A 59 years old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number/expiration date unknown) on 02Apr2021 at single dose via an unspecified route of administration for COVID-19 immunization. Relevant medical history included suspected Covid- 19 and cough as reported that patient thought he had the virus last year because he had a cough that wouldn't go away for about 3 months and he had to take over the counter OTC medicines. Concomitant medications were not reported. The day after vaccination patient experienced swelling all over his face, He stated he had big "water bags" under his eyes (as such). He thought he had angioedema. He wanted also to confirm that he shouldn't get the second vaccine. At the time of the reporting events outcome was unknown.   Information on the lot/batch number has been requested.
Severe headache; Severe muscle and joint aches; Severe muscle and joint aches; Could not sleep all night; Mild nausea; Chills; Hot flashes; Burning lungs; Scratchy sinuses; Sore throat; Severe fatigue; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 23Apr2021 at 16:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and portal vein thrombosis (PVT). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), cyanocobalamin-tannin complex (B12), one a day multi-vitamin (MANUFACTURER UNKNOWN) and cannabidiol (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 02Apr2021 at 11:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. On 24Apr2021 at 11:00, the patient experienced severe headache, severe muscle and joint aches (could not sleep all night because it hurt so bad), mild nausea, chills, hot flashes, burning lungs, scratchy sinuses, sore throat and severe fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe headache, severe muscle and joint aches (could not sleep all night because it hurt so bad), mild nausea, chills, hot flashes, burning lungs, scratchy sinuses, sore throat and severe fatigue was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Client received the Booster COVID Vaccine (Pfizer, Lot#FF8841) at 1310.  At 1320 Client got up to go to the bathroom.  At 1324 Client  reported feeling weak, dizzy, cold, nauseous, and clammy.   Observation RN alerted Lead RN.  Observation RN responded and moved client to anti-gravity chair.  At 1325 vitals assessed (BP 120/84, HR 72, O2 96%, R 12, alert and oriented x 4).  Client  was provided juice.  Client  reports history of panic attacks and currently taking Buproprion and Citalopram.  Client  denies any allergies.  Client  reports immediately feeling better after juice. At 1345 vitals assessed (BP 112/72, HR 76, O2 98%, R 12, alert and oriented x4).  Client  continues to rest and reports feeling better. At 1352  sat up in anti-gravity chair and at 1355 Client felt better and wanted to stand up and walk in observation room.  At 1358 Client  educated on signs/symptoms when to seek medical care and to follow-up with primary care provider.  Client left with steady gait.
pt recv vax SPE95 & APR97 pt exp less than 50 lesions;
Summary Note: Rash, itching, hives, SOB, hypotension, hypoxia, hypothermia, bradycardia, muscle pain and aches, severe headache, nausea, vomiting, diarrhea, lethargy, severe site pain right upper arm 2" below injection site measuring approximately 2" x 3" with rigid hardness at site.
pt recvd vax;exp swollen,red,burning,itching & heat radiating from inject site;2 days later, had a hard lump;tx w/ apap & hot packs; 4 days later,lump & bruise were smaller & inject site burning & itching;7 days later almost gone
Nausea; Muscle aches all through body; Had a temperature of 1 100.1/ My Temperature was 98.8 normal.; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0150) via an unspecified route of administration in the right arm on 17Apr2021 at 09:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was unknown whether the patient received any other vaccines within four weeks prior to the vaccination. The patient received unspecified medications in two weeks. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6204) via an unspecified route of administration in the right arm on 25Mar2021 at 13:45 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. On 18Apr2021 at 00:00, the patient experienced body temperature of 100.1 (unspecified units), nausea and muscle aches all through his body. On 19Apr2021, the patient body temperature was 98.8 (unspecified units) which was normal. On 18Apr2021, the patient underwent lab test which included body temperature and result was 100.1 (unspecified units). On 19Apr2021, the patient again underwent lab test which included body temperature and result was 98.8 (unspecified units). And all his symptoms were now gone for the most part at the time of this report. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event body temperature was recovered on 19Apr2021, while that of the events nausea and muscle aches all through body was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Severe nausea that required trip to Urgent Care for antinausea medication; nausea continued for 18 hours even if Zofran taken every 4 hours orally
Localized heat in spine on second day, moved to base of skull on days 3-9 (feels like heat stroke with similar slow thinking and fatigue).   Heat and mild itching in face day 3. Progressed into rash - hot to the touch, uncomfortable, moderate itchiness. Rash became worse on day 6. Spread to throat and chest on day 9. Became morbilliform rash on day 10. Severe heat and itching. Moderate pain and swelling. Began to spread to upper abdomen at the end of day 10.
itching, redness & slight soreness in injection area along left arm, slight nervousness, mild scratchy throat/cough post injection.  Patient took P/O Ephedrine hydrachloride & Diphenhydramine hydrachloride
SHORTNESS OF BREATH; TIGHTNESS IN HER CHEST AS IF SHE HAD HEARTBURN, BUT IT IS NOT HEART BURN; FEELING UNDER THE WEATHER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included hives possibly due to preservatives in food, and allergy to possibly preservatives in food.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 03-JUL-2021 for prophylactic vaccination. The batch lot number was not reported and has been requested. No concomitant medications were reported. On 04-JUL-2021, the subject experienced shortness of breath. On 04-JUL-2021, the subject experienced tightness in her chest as if she had heartburn, but it is not heart burn. On 04-JUL-2021, the subject experienced feeling under the weather. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from shortness of breath, and tightness in her chest as if she had heartburn, but it is not heart burn, and the outcome of feeling under the weather was not reported. This report was non-serious.; Sender's Comments: Medical assessment comment not required as per standard operating procedures, as case was assessed as non-serious.
sick for 3 weeks afterwards with flu symptoms; flu symptoms; Initial information received on 12-Oct-2022 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case is linked to cases 2022SA424503(CLUSTER), 2022SA425041(CLUSTER), 2022SA424529(CLUSTER) and 2022SA425046(CLUSTER).  This case involves an elderly female patient who was sick for 3 weeks afterwards with flu symptoms and flu symptoms while receiving vaccine influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect influenza vaccine once produced by unknown manufacturer (lot number: not reported; dose, strength, formulation and expiry date unknown) via unknown route in unknown administration site for immunization.  On an unknown date the patient got sick for 3 weeks afterwards with flu symptoms (illness)  and symptoms (influenza) (unknown latency) following the administration of influenza vaccine .  It was reported Three years ago, she received a "senior" flu shot from pharmacy. The caller does not know which senior flu shot his wife received. She got sick for 3 weeks afterwards with flu symptoms. She now says that she will never get another flu shot, after what she experienced 3 years ago.   Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the events (sick for 3 weeks afterwards with flu symptoms, flu symptoms).  At time of reporting, the outcome was Recovered / Resolved on an unknown date for both the events.
Dizziness started around the second day after receiving the vaccine.  Today is the 4th day after and I am still having bouts of dizziness.  It's not enough that I need to sit down, although it is somewhat disorienting.
Severe chills, burning joints (all joints, even joints patient was previously unaware of), fatigue; I couldn?t get out of bed even to get glass of water for 12 hours; fatigue, intermittent chills and fever continued for 24 hours then subsided. But elbow joint pain (never previously experienced) continues to hamper daily activities
After i got my shot at about 5:30 not only did my arm start to hurt at the injection site. My feet started to hurt, the pain went from my feet to my knees to hips up my back arms to my neck. and into my hands. the pain wasn't in my joints. The pain was that of a Fibro flare, x10. The worst body pain I can't even explain. Muscle spasms in the palms of my hands that have lasted for 4 days. Foot pain that makes walking very painful. Back pain that makes it hard to sit up, hard to lay down. Pain that keeps you awake. Skin feeling like it's on fire. intense pain 72 hours, THe pain I have doesn't respond to OCT or muscle relaxers. I can't get comfortable.
Patient reported to RN that she had severe allergic reaction after the vaccine. Face was swollen, but it improved.
Reports swelling L thigh, hot, induration 9x3cm pain/tender erythema mass, L inguinal swelling.
PHARMACYLEFT PFIZER VIALS IN THE FREEZER FOR LONGER THAN 2 WEEKS AT THE TEMPERATURE (-25 AND -15 DEGREES C). WE GAVE OUT DOSES FROM THESES VIALS RENDERINGTHEM POSSIBLY LESS EFFECTIVE
This spontaneous report was received from a Registered Nurse and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. In May 2016, the patients were vaccinated with the improperly stored dose of VAQTA lot # L031196, expiration date on 05-FEB-2017, lot number reported as: M009377, expiration dates on 30-JUN-2017 and 17-JUN-2017; dose was not reported. No adverse events were reported. Administered dose of vaccine experienced the temperature excursion of 48 degrees Fahrenheit for 50 minutes. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same source. Additional information has been requested.
Began as slight nausea and progressed to lethargy and memory loss followed by symptoms related to endocrine system, e.g., drastic drop in testosterone determined by primary care physician.  Symptoms progressed within days to drastic memory loss and confusion and within approximately three to four weeks to mri diagnosing inflammation of the brain presenting as 3 lesions positioned in center of brain positioned directly on hypothalamus.  Initial diagnosis as potential lymphoma or neurosarcoidosis to completely "rare" as described hematologist/oncologist, Dr., and eventually neuro oncologist, Dr., Hospital. Hospitalization on April 27, 2022 into Hospital Neuro  Critical Care with complete shutdown of endocrine system stemming from brain inflammation.
Severe stomach cramps occurred 4-5 hours after each dose. Cramps lasted 4-6 hours after each dose.
A few weeks after my second Lymerix vaccine I started to get severe pain in both my left and right forearms. The pains then started to travel to different parts of my body, hands, legs, arms (everywhere). Swelling of the hands and finger in this time period I went from no rheumatood factor to a high factor. I am ready to refill my prescription of Lipitor and have a question for you. I am not sure if there is a correlation but for the last two to three months I have had pain in my forearms and or elbow joints. At first I thought this was caused by some physical work that I have done. For the last month I have eliminated that possibility but still have the symptoms. Is there an alternative to Lipitor that I can try to see if I could reduce the stiffness and pain? Requested to evaluated by MD. Delightful fellow who works in IT but is also on search and rescue. During the course of this he was immunized at least three injections of hepatitis vaccine in two of the Lyme vaccine. He developed generalized aches and pains, perhaps some swelling in the small joints of the feet and hands. He is not sure. In the course of the workup he was also placed on Lipitor was discontinued. He was continued with morning stiffness, generalized, moderate in severity but less than one-half hour. Swelling of the joints has dissipated. There are some aches and pains. He has some fatigue but no fever or other constitutional symptoms. He denies skin rashes, sun sensitivity or any known tick bites. He has tried some Celebrex with minimal improvement. No neck or low back pain, painful red eye, bloody diarrhea, pleuritic chest pain or fever. Pain on the bottom of the feet when he walks. Has seen a foot specialist and was told it was "tendons." Follow up labs including quantitative titer of rheumatoid factor and western blot on the lyme antibody, ANA, CPK. Continue Celebrex, 200mg daily. HLA-B27 antigen. Rheumatoid arthritis, serologically positive. Pt has some mild synovitis in a small joints of the hands. Begin Methotrexate 10mgs q week. Begin Sulindac 200 mgs twice a day, in place of Celebrex. RTC three weeks for monitoring of potential toxicities and efficacy. Due to the high concentration of rheumatoid factor, I will probably obtain a chest x-ray when he returns, as well as a baseline set of hand films, to check for joint erosions and space narrowing in the future.
Information has been received from a consumer regarding a case in litigation concerning his child who was diagnosed with autism shortly after receiving a dose of MMR II. Upon internal review, autism was determined to be an other important medical event. No further information is available.
patient got very sleepy and must have slept on and off for about patient would say 30 hours; patient just could not wake up; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SOMNOLENCE (non-serious) with onset 2021, outcome "recovered" (2021), described as "patient got very sleepy and must have slept on and off for about patient would say 30 hours; patient just could not wake up".  Additional information included: Patient would receive the second dose of vaccine on 18Mar2021. The patient came out of it but wanted to get the second shot but was afraid that it might be worse and the patient did not want it to be worse.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
approx 7mo p/vax pt devel streptococcal pneumonia & was hosp;pt was recovered @ the date of this report;
She got her vaccine, she was okay.  The next morning her arm was a little bit painful but nothing.  Then she woke up and it was terrible, she had a headache, chills with constant shaking, no temperature.  She cannot sleep due to the chills after having a couple of blankets due to the shaking.  She has arm pain and leg  pain and very dizzy and worried about falling.  She is also tired.  She has been taking Tylenol which has not helped her much.  Her liver started aching and she stopped taking it.  She has not called her doctor yet.
Muscle pain in both shoulders, neck and both arms and fatigue that has lasted since the day after the vaccine was administered.  Prior to vaccine, I was energetic and worked out vigorously every day for 60 min (20 mile bike ride and weight lifting).  Typical muscle sored prior to vaccine was a day or 2 after increasing weights.  Now, I can only work out 2 days a week.  Muscles ache constantly and I cannot sleep because of the pain.  Ibuprofen only helps a little.  Prior to the vaccine I slept 7-8 hours a night.  Since the vaccine, I am sleeping 10 hours and am still tired.
fever 100.6 degrees; Nausea; Chills; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 67-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EM9809) via an unspecified route of administration, administered in arm left on 25Feb2021 13:00 (at the age of 67-year-old) at dose 2, single for covid-19 immunisation. Medical history included IBS (Verbatim: IBS). Reported she has a history of IBS, but she does not think the IBS was relevant to what she was experiencing now. No further details provided. Concomitant medications were not reported. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL9264) via intramuscular route of administration, administered in arm right on 04Feb2021 (at the age of 67-year-old) at dose 1, single for covid-19 immunisation. On 26Feb2021 the patient experienced fever 100.6 degrees, nausea, chills. Reported she received her second Pfizer COVID-19 Vaccine yesterday, and now is running a 100.6 degree fever. She said she had all the symptoms listed for the COVID-19 Vaccine. Reporter asked if she can take Tylenol, or should she just leave her symptoms alone. Reporter stated she did not want to mess up the effectiveness of the COVID-19 Vaccine by taking Tylenol if she was not supposed to. Reporter was advised she would be transferred to Pfizer Medical Information for further assistance with her question. Reported her husband had received his second COVID-19 Vaccine dose at the same time she received hers, and her husband was fine. No further details provided. Reported she received her second Pfizer COVID-19 Vaccine yesterday, and now is running a 100.6 degree fever. Reported her symptoms occurred approximately 12 hours after she received her second COVID-19 Vaccine (between 1:00AM-2:00AM on 26Feb2021). She said she had all the symptoms listed with the COVID-19 Vaccine information, specifically stating nausea, chills, and fever. Reported she received her first COVID-19 Vaccine on 04Feb2021, providing Pfizer Lot Number: EL9264. She said her first dose of the COVID-19 Vaccine was administered in her right arm. She said there was no NDC or Expiration Date listed on her COVID-19 Vaccination card. The patient underwent lab tests and procedures which included body temperature: 100.6 degrees on 26Feb2021. Events did not require a visit to emergency room, physician Office. Outcome of the events was not resolved.  No follow up attempts are possible. No further information is expected.
injection site soreness; This is a spontaneous report from a contactable consumer (Patient).  A 44-year-old (also age at vaccination) male patient receive the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL1283), via an unspecified route of administration at the left arm on 09Jan2021 (reported as 29Jan2021; pending clarification) 08:30 at SINGLE DOSE for covid-19 immunization. Medical history included that prior to vaccination the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had no allergies to medications, food, or other products. The patient was vaccinated at a workplace clinic. The patient's concomitant medications were not reported. It was reported that the patient experienced injection site soreness on 30Jan2021 (as reported date: pending clarification). The outcome of the event was recovering. The treatment received is Diclofenac 100mg. Case was not considered serious (for any criteria).